GMO omega-3 canola cleared by USDA, on its way to consumers

why canola oil is bad for you
Credit: Small Footprint Family

Nuseed, a subsidiary of Nufarm, Ltd. of Australia, has received approval from the U.S. Department of Agriculture to start planting its proprietary omega-3 canola, according to Food Navigator. The decision brings plant-derived long-chain omega-3s a step closer to the U.S. market ….

This plant appears to have the potential to significantly limit the number of fish that would have to be harvested for omega-3 purposes. According to Nuseed, one hectare …. of its proprietary canola could produce the same amount of DHA oil that can be extracted from 10,000 one-kilogram fish.

[T]he oil from the plants can’t be used for food or feed applications unless the U.S. Food and Drug Administration gives Nuseed regulatory approval. The company told Food Navigator it anticipates receiving that approval before the 2019 growing season.

Nuseed already received approval earlier this year from Australian authorities to plant its proprietary canola and include the oil in food and feed in that country ….

According to Grand View Research, the global omega-3 market was valued at $2.04 billion in 2016 and was projected to increase at a compound annual growth rate of 6.6% between 2012 and 2022. That’s undoubtedly why Nuseed, plus other companies such as Cargill, are developing plant-based omega-3 products to bring to market.

Read full, original article: USDA approves GM omega-3 canola for US cultivation

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
Screenshot-2026-05-21-at-12.15.17-PM
UK gene-editing milestone: Livestock barley that increases ruminant value and reduces methane emissions is first-approved CRISPR crop
Screenshot-2026-05-21-at-3.15.53-PM
Chiropractors may no longer be modern-day snake oil salesmen, but the benefits of their therapy are limited–at best

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.